Smartox-Biotech
Smartox Biotechnology
離子通道研究用多肽**的專業(yè)化生產商
Smartox Biotechnology是全球唯壹一家專門生產動物毒液多肽**，用于細胞離子通道功能研究的生物醫(yī)藥公司。多肽**在生物制藥領域具有重要的使用價值。
Smartox Biotechnology于2009年由來自Grenoble神經科學研究所(Grenoble Institute of Neuroscience)的Michel de waard博士創(chuàng)立,Smartox Biotechnology專門研究動物毒液，制作合成多種毒液中的多肽成分（常稱為**）。De Waard博士研究離子通道與**多肽的關系，尤其是鑒定、開發(fā)**多肽作為**性分子或細胞穿透肽(cell penetrating peptides, CPP)。其研究團隊在毒液分離，藥理性活性肽鑒定、富半胱氨酸肽定性、制作和優(yōu)化等方面具有獨特、豐富的經驗。2010年，Smartox Biotechnolgy被法國研究部(Ministry of Research)授予“新興企業(yè)OSEO獎(OSEO prize for emerging businesses)”。
總之，Smartox Biotechnology提供一系列高質量、具開創(chuàng)價值的多肽**。這些化合物在離子通道 研究中具有高的親和性和選擇性，是相應領域科學研究理想的生物**提供商和貼心的合作伙伴。
Smartox Biotechnology的**產品包括：
鈉離子通道(Sodium channel)
|
Toxin name |
Catalog # |
Target |
|
Phrixotoxin-3 |
13PHX003 |
Selective blocker of Nav1.2 |
|
μ-conotoxin GIIIB |
CON020 |
Selective blocker of Nav1.4 |
|
μ-conotoxin CnIIIC |
CON021 |
Selective blocker of Nav1.4 |
|
μ-conotoxin PIIIA |
08CON006 |
Selective blocker of Nav1.4 |
|
Jingzhaotoxin-III |
12JZH003 |
Selective blocker of Nav1.5 |
|
ProTx-II |
07PTX002 |
Selective blocker of Nav1.7 |
|
ProTx-II Biotin |
12PTB002 |
Selective blocker of Nav1.7 |
|
ProTx-I |
12PTX001 |
Blocker of Nav1.8, Nav1.2, Nav1.5, Nav1.7 |
|
Huwentoxin-I |
07HWT001 |
Blocker of TTX-S |
|
Huwentoxin-IV |
08HWT002 |
Blocker of TTX-S |
|
Hainantoxin-III |
13HTX003 |
Blocker of TTX-S |
|
Hainantoxin-IV |
12HTX001 |
Blocker of TTX-S |
|
GsAF-I |
12GSF001 |
Blocker of TTX-S |
|
GsAF-II |
12GSF002 |
Blocker of TTX-S |
鉀離子通道(Potassium channel)
|
KCa channels |
|||
|
Toxin name |
Catalog # |
Target |
Description |
|
Apamin |
08APA001 |
SK1, SK2, SK3 |
|
|
Charybdotoxin |
11CHA001 |
KCa1.1, KCa3.1 - Kv1.2, Kv1.3, Kv1.6 |
|
|
Iberiotoxin |
12IBX001 |
KCa1.1 |
|
|
Leiurotoxin 1 (Scyllatoxin) |
10LEI001 |
SK1, SK2, SK3 |
|
|
Tamapin |
10TAM001 |
SK1, SK2, SK3 |
|
|
Kaliotoxin-1 |
08KTX002 |
BK, Kv1.1, Kv1.2, Kv1.3 |
|
|
Kv channels |
|||
|
ShK |
08SHK001 |
Kv1.3, Kv1.1, Kv1.4, Kv1.6 |
|
|
TMR-ShK |
SAT001 |
Kv1.3, Kv1.1 |
|
|
Margatoxin |
08MAG001 |
Kv1.3 |
|
|
(Dap22)-ShK |
13SHD001 |
Kv1.3 |
|
|
ADWX-1 |
13ADW001 |
Kv1.3 |
|
|
HsTx1 |
08NEU001 |
Kv1.3, Kv1.2 |
|
|
Agitoxin-2 |
13AGI002 |
Kv1.3, Kv1.1 |
|
|
Maurotoxin |
08MAR001 |
Kv1.2, KCa3.1 |
|
|
Guangxitoxin 1E |
11GUA002 |
Kv2.1, Kv2.2 |
|
|
Stromatoxin 1 NEW |
SCT01 |
Kv2.1, Kv2.2 |
|
|
Kaliotoxin-1 |
08KTX002 |
BK, Kv1.1, Kv1.2, Kv1.3 |
|
|
Charybdotoxin |
11CHA001 |
KCa1.1, KCa3.1 - Kv1.2, Kv1.3, Kv1.6 |
|
|
Phrixotoxin-2 |
PHX002 |
Kv4.2, Kv4.3 |
|
|
AmmTx3 NEW |
AMX001 |
A-type potassium channels |
|
|
Inwardly rectifying potassium channels |
|||
|
TertiapinQ |
08TER001 |
Kir1.1, Kir3.1/3.4, Kir3.1/3.2-KCa1.1 |
|
|
hERG/Kv11.1 |
|||
|
BeKm-1 |
13BEK001 |
ERG1 |
|
鈣離子通道(Calcium channel)
|
High voltage-gated Ca2+ channels |
|||
|
Toxin name |
Catalog# |
Target |
Description |
|
ω-agatoxin IVA |
11AGA001 |
P/Qtype |
|
|
ω-Conotoxin MVIIC |
08CON002 |
P/Qtype, N-type |
|
|
ω-Conotoxin MVIIA |
08CON001 |
N-type |
|
|
ω-Conotoxin GVIA |
08CON003 |
N-type |
|
|
ω-Conotoxin SO3 |
08CON013 |
N-type |
|
|
Huwentoxin I |
07HWT001 |
N-type |
|
|
ProTx-II |
07PTX002 |
T-type, L-type |
|
|
Intermediate voltage-gated Ca2+ channels |
|||
|
SNX482 |
08SNX002 |
R-type |
|
|
Low voltage-gated Ca2+ channels |
|||
|
ProTx-I |
12PTX001 |
T-type |
|
|
ProTx-II |
07PTX002 |
T-type, L-type |
|
|
Maurocalcine |
07PAU001 |
Ryr1 |
|
氯離子通道(Chloride channel)
|
Toxin name |
Catalog # |
Target |
Description |
|
Chlorotoxin |
08CHL001 |
Blocker of small conductance Cl- channels |
|
|
GaTx1 |
13GTX001 |
Selective blocker of CFTR channel |
|
|
GaTx2 |
10GTX002 |
Selective blocker of ClC-2 channel |
乙酰膽堿受體(Acetylcholine receptor)
|
Toxin name |
Catalog # |
Target |
Description |
|
α-conotoxin PeIA |
13CON017 |
α9α10, α3β2 subunits |
|
|
αC-Conotoxin PrXA |
13CON016 |
α1/β1/ε/δ, α1/β1/γ/δ subunits |
|
|
Waglerin-1 |
12WAG001 |
MusclenAChR |
|
|
α-conotoxin MI |
08CON012 |
α1/δsubunits |
|
|
α-conotoxin GI |
08CON005 |
α/δsite |
|
|
α-conotoxin IMI |
08CON011 |
α7 homomeric nAChR |
|
|
α-conotoxin GID |
CON019 |
含N-甲基-D-天冬氨酸NR2B (NMDA, NR2B containing N-methyl-D-aspartate)
Conantokin-G選擇性、特異性抑制含NR2B的NMDAR。Conantokin-G能劑量依賴性抑制Ca2+內流，抑制NMDA誘導的興奮性中毒效應。研究表明，在小鼠皮層神經元，Conantokin-G阻滯NMDA引發(fā)的電流信號的IC50值為480 nM。
酸敏感離子通道(ASIC channel, Acid-Sensing Ion Channel)
|
Toxin name |
Catalog # |
Target |
Description |
|
APETx2 |
07APE002 |
Selective blocker of ASIC3 |
|
|
Psalmotoxin1/PcTx1 |
13PCT001 |
Selective blocker of ASIC1a |
|
|
Ugr9-1 |
13UGR001 |
Blocker of ASIC3 |
瞬時受體電位(TRP channel, transient receptor potential)
|
Toxin name |
Catalog # |
Target |
Description |
|
GsMTx4 |
08GSM001 |
TRPC, TRPA |
|
|
Vanillotoxin3 |
10VAN003 |
Activator of TRPV1 |
|
|
ProTx-I |
12PTX001 |
Antagonist of TRPA1 |
嘌呤能通道(Purinergic channel)
Purotoxin-1
選擇性抑制P2X3受體。100 nM Purotoxin-1 (PT-1)選擇性抑制P2X3受體通道，在大鼠DRG神經元上，使用膜片鉗實驗表明：PT-1對電壓門控通道和TRPV1均無抑制效應。10 μM ATP和100 μM α,β Methylene-ATP濃度下Purotoxin-1對P2X3受體有選擇性作用，在該ATP濃度下Purotoxin-1對P2X2和雜化二聚體P2X2/3并無激動作用。
Purotoxin-1對疼痛的潛在**作用。
其它膜受體通道(Others)
Smartox Biotechnology還提供其他類型的膜受體抑制劑：
|
Toxin name |
Catalog# |
Target |
|
Morphiceptin |
011CAS001 |
Agonist of μ-opoid receptors |
|
Lys-conopressin G |
11CON14 |
Vasopressin-like peptide |
|
GsMTx4 |
08GSM001 |
Mechano sensitive ion channels |
|
Obtustatin |
10OBT001 |
Blocks the binding of α1β1 integrin to collagen IV |
|
Rho-Conotoxin TIA |
CON022 |
Blocks α1-adrenergic receptor |
